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Wade Davis’s study of Haitian “zombiﬁcation” in the 1980s was a landmark in ethnobiological research. His research was an
attempttotracetheoriginsofreportsof“undead”Haitians,focusingonthepreparationofthezombiﬁcationpoison.Startingwith
this inﬂuential ethnopharmacological research, this study examines advances in the pharmacology of natural products, focusing
especially on those of animal-derived products. Ethnopharmacological, pharmacological, and chemical aspects are considered. We
also update information on the animal species that reportedly constitute the zombie poison. Several components of the zombie
powder are not unique to Haiti and are used as remedies in traditional medicine worldwide. This paper emphasizes the medicinal
potential of products from zootherapy. These biological products are promising sources for the development of new drugs.
1.Introduction
Ethnopharmacological studies have been extensively dis-
cussed as a promising strategy for development and dis-
covery of new medical and pharmaceutical products [1].
Ethnopharmacology relies on accumulated cultural experi-
ences with nature to aid in identifying bioactive molecules.
There is evidence that ethnographically directed studies may
be more eﬃcient than other bioprospecting strategies; how-
ever, most of these studies have focused on the use of plants
[1].Gertsch[2]hasarguedthatmanyofthepharmacological
activities attributed to natural products are merely artifacts
from data extrapolations, particularly in in vitro studies [3],
and unreliable assays. This suggests a basic question: why
have pharmacological investigations of thousands of plants
and animals yielded so few products? One of the main rea-
sons is a disconnection between investment and research; the
large investments made for screening these compounds are
not matched by those for research.
These ﬁndings emphasize the diversity of molecules and
commercial drugs that result from ethnographically directed
investigations. Such research, despite its potential for devel-
oping new drugs, has not attracted signiﬁcant amounts
of investment. Coordinated eﬀorts to advance this mode
of drug discovery are in their initial stages. Signiﬁcantly,2 Evidence-Based Complementary and Alternative Medicine
increasing numbers of leads are derived from animal prod-
ucts [4], although ethnodirected eﬀorts related to the fauna
are still scarce.
Like plants, animals have been a source of medicinal
treatments since antiquity. Their presence in the pharma-
copoeia oftraditionalpopulations [5]isc o nsid e r eduni v e r sal
bymanyresearchers.Thehypothesisofuniversalzootherapy,
for example, postulates that every human culture that has
developed a medical system utilizes animals as a source of
medicine [6].
The ubiquity of animals in folk medicine is illustrated
by studies of ethnobiology worldwide [7–11]. These studies,
which have attracted increasing academic interest in recent
years, have found a great deal of diversity in the animals
used for therapeutic purposes, including insects [12, 13],
vertebrates [7, 14, 15], and marine invertebrates [16, 17].
Studies of medicinal animals can assist in pharmacological
screening and may serve both as a source of medicine and as
a measure of economic value for these species [18].
In a review of new drugs from natural products, Harvey
[19] reported 24 drugs based on animals and 108 based on
plants, which suggests that animals are still poorly studied.
Moreover, many pharmacological studies of animals did not
report use of ethnographic information [20, 21].
This work examines the state of ethnodirected pharma-
cology in two ways. First, based on anthropologist Wade
Davis’s 1986 description, the components of the traditional
Haitian “zombie powder” poison were studied. For the ani-
mal species involved in the poison preparation, we examine
nomenclatural changes, geographic distributions, origins,
ecological data, and conservation status. For the plants in-
volved, we brieﬂy review their current ethnobotanical uses,
phytochemistry, and pharmacology as measures of the
progress made since the Davis’ report. We also discuss how
ethnographic information about animal-derived medicines
is used in present-day pharmacology and the relative scarcity
of animal-derived products in natural product libraries. This
paper suggests that traditional knowledge about animals can
assist in locating potential therapeutic agents and is expected
to ﬁll gaps in knowledge about the traditional use of this
resource.
Published ethnopharmacological reports regarding me-
dicinal animals and plants were analyzed. For animals, re-
ports and secondary documents describing medicinal an-
imal use and pharmacological reports describing the use of
traditional zoological products were used. Documents were
obtained from Science Direct (http://www.sciencedirect
.com/), Scirus (http://www.scirus.com/), Google Scholar,
Scopus (http://www.scopus.com/), Web of Science (http://
www.isiknowledge.com/), and Biological Abstracts (http://
www.science.thomsonreuters.com/) using the following
search terms: “Zootherapy + Biochemistry,” “Ethnozoolo-
gy+Bioactivecompounds,”“Ethnozoology+Biochemistry,”
“Medicinal animals,” “Ethnozoology + Pharmacology,” and
“Ethnopharmacology + Animals.” Review papers were ex-
cluded. A database characterizing the general proﬁle of the
studies and aspects related to the animal’s popular and
pharmacologicaluseswasassembled.Insomecases,thestud-
ies dealt with pharmacological analyses of more than one
animal species, but only provided information regarding the
popular use of one. In these cases, only species with both
pharmacological and popular use data were incorporated
into the database.
Ethnobotanical,phytochemical,andpharmacologicalin-
formation describing each of the plant species described by
Davis [22] was assembled. First, the Scirus database (http://
www.scirus.com/), which includes Science Direct, MedLine,
and PubMed and Google Scholar were searched using the
searchterms“[scientiﬁcspeciesname]ANDethnobotanicals,”
“[scientiﬁc species name]A N Dp h a r m a c o l o g y , ”“ [ scientiﬁc
species name] AND chemical composition”, and “[scientiﬁc
species name] AND molecules;” review articles were also
considered. Patent records were searched using the Scirus
databasewiththesearchterms“[scientiﬁcspeciesname]AND
medicine” and “[scientiﬁc species name]A N Dd r u g s . ”F o r
species with few related scientiﬁc studies, we also performed
a supplementary search at the Natural Products Alert data-
base (NAPRALERT). It is not our intention to present an
exhaustive review of the secondary literature, but rather to
give an overview of the literature pertaining to these species.
2. Ethnobiology of the Zombie Poison
2.1. Landmark: Wade Davis—The Serpent and the Rainbow.
Travel narratives are a longstanding source of information
about America’s peoples and environment. Foreign visitors
undertook the process of developing a nomenclature for the
newly discovered regions. In the 1980s, writing in this mode,
Davis contributed a landmark piece of ethnopharmacologi-
cal research.
Davis was born in BC, Canada, in 1953. He studied at
Harvard the University, where he graduated with a doc-
torate in ethnobotany. He studied various Indian tribes,
providing him with wide-ranging experience and making
him a renowned ethnobotanist and photographer [23]. He
has written and continues to publish books and scholarly
articles. One of his major contributions involves his ethno-
pharmacological study of “zombie poison.”
ThisresearchbeganafterDavishadcompletedhisstudies
at Harvard and returned there as an assistant to Richard
Evans Schultes. Schultes, a professor at the Botanical Muse-
um of Harvard, studied the ethnobotany of the Indians of
Northwest Amazon. He was particularly interested in me-
dicinal plants, particularly hallucinogens, seeing such study
a possible source of new medicines.
In1982,SchultesaskedDavistotraveltoHaitito“initiate
the search for the Haitian zombie poison” [22]a n dt od e -
velop research suggested by Nathan Kline, a psychiatrist
studying psychopharmacology, and Heinz Lehman, the di-
rector of the Department of Psychiatry and Pharmacology
at the McGill University. Kline told Davis, “if we could ﬁnd
a new drug that the patient became deeply insensitive to
pain and paralyzehim, and another to returnhim harmlessly
to normal consciousness, this would revolutionize modern
surgery” [22]. Lehman added, “That’s why we meet to
investigate all reports of potential anesthetic agents. We must
lookmorecloselyatthissupposedzombiepoison,ifitexists”Evidence-Based Complementary and Alternative Medicine 3
[22]. Kline aﬃrmed that the “undead” [22], or “zombies,”
were victims of Vodou practitioners.
Davis hypothesized the existence of an anesthetic,
which, administered in adequate dosage, would reduce the
metabolism of the victim to the point that he or she would
be considered dead. However, the victim would remain alive
and could be revived with the administration of an antidote.
Such a drug would have broad medical and pharmacological
potential. At the time, this process even attracted the interest
of NASA as a model of artiﬁcial hibernation [22].
Davis aimed to discover “the frontier of death” [22], as
Lehman put it. He traveled to Haiti to ﬁnd Voodoo practi-
tioners and obtain samples of the zombie poison and anti-
dote, observing Voodoo preparation and recording their use.
Davis stood out among ethnobotanists for his work on the
“zombiﬁcation” process, in which he strove to be systematic
and objective. His work described and contextualized the
process, its mystique, and the animal and plant species
involved. This research forms the foundations of our knowl-
edge of the anesthetic contained in the zombie poison.
Davis’travelchronicle,TheSerpentandtheRainbow[22],
provided important insights and observations about this
phenomenon. He described it as “an elusive phenomenon
that [he] had diﬃculties to believe” [22]. His investigations
ofthezombiephenomenonwereofgreattechnical,scientiﬁc,
and marketing relevance. Davis describes zombiﬁcation in
long passages of his narrative, leaving a rich commentary on
what he saw.
2.2. Zombiﬁcation: Theory and Practice. Since 1915, when
Haiti was occupied by the United States of America, zom-
biﬁcation has attracted interest in western culture [22, 24].
From the standpoint of western psychiatry, a “zombie” is
deﬁned as a female or male individual that has been poi-
soned, buried alive, and resurrected. These individuals man-
ifest symptoms that would be classiﬁed as a catatonic schizo-
phrenic, characterized by inconsistency and catalepsy, alter-
nating between moments of stupor and activity [22]. As
described by Davis, the word “zombie” had meaning rooted
in the culture and beliefs of the Haitian peasant society.
“Precisely the Haitian deﬁnition of zombie [is of] a body
without character, without will”[ 22] ;az o m b i ei s“ u n d e a d ”
[25] and in a state of lethargic coma. A zombie, in this sense
of the word, is identiﬁed through its lifeless expression, nasal
intonation, and repeated and limited actions and speech.
“Zombiﬁcation” is a religious practice related to Voodoo.
From the perspective of Voodoo, zombies are created by
witchcraft, an essentially magical phenomenon. These beliefs
regarding the natural and supernatural worlds developed
over Haiti’s history of colonization and intermarriage and
are a synthesis of the religious beliefs of Haiti’s original
inhabitantswiththoseofAfricanoriginandEuropeanChris-
tianity [26, 27]. The zombie poison powder was controlled
by Haitian secret societies with roots in West Africa. The
poison was and still is used as a form of sanction for those
who “violated the codes of society”. In Haiti, zombies are not
themselves considered objects of fear; rather, popular fear
focuses on becoming a victim of zombiﬁcation [22, 28].
In Haiti, the estimated number of new zombiﬁcations
exceeds one thousand cases per year [28]. Despite its ap-
parent prevalence, Haiti classiﬁes this practice as criminal
activity tantamount to murder (Article 246 of the Criminal
Code of Haiti).
In his publications, Davis suggested that zombies in Haiti
were “produced, made,” in contrast to the image of folkloric
zombies [29]. He showed the existence of zombies using
the rational methods of western science, revolutionizing the
ethnographic narrative when placed in the ﬁrst person [29].
Reﬂecting on his research on the zombie poison, Davis said:
“[...] it is implied that its main chemical components had to
be topically active. For descriptions of wandering zombies, it
seemed likely that the drug induces a prolonged psychotic state,
whereas the initial dose had to be capable of causing a stupor
similar to death. Since, in all probability, the poison was an
organic derivative, its source had to be a plant or an animal
commonly found in Haiti. Finally, whatever was the substance,
it should be of an extraordinary power.”
Davis was especially interested in the plant and animal
species used to prepare the poison: “[carried] a kaleidoscopic
Haitian bag built of empty cans of soda. The specimens that
I ﬁlled included lizards, a polychaete worm, two marine ﬁsh
and numerous tarantulas—all preserved in alcohol—as well
as several bags of dried plant material. Two bottles of rum
contained the antidote, while the poison itself was in a glass
jar [...]” [22]. He later added: “ I ft h em y s t e r yo ft h ez o m b i e
phenomenon had to be resolved, these specimens were the most
important clues. Without them, there was nothing concrete.”
Davis’ descriptions of zombiﬁcation continue to have
great relevance as records of the process of bringing a person
apparently dead to life and have come to play an important
role in the pharmaceutical industry’s understanding of
ethnography as a source of new drugs. Within this context,
Davis’ publications provoked a great deal of controversy in
the foreign press. Most reports suggested that his writing
combined folklore, culture, ethnobotany, and pharmacology
[29, 32]. Similarly, many reported, often with a tone of
censure, that Davis caricatured Voodoo as a closed cultural
system, ignoring changes since its formation in the eight-
eenth century [29, 33].
Therearemanydescriptionsofzombiesandthepractices
surrounding zombiﬁcation, ranging from scientiﬁc reports
and doctoral dissertations to popular movies, computer
games, magazines, websites, and numerous other forms of
cultural expression [26, 34, 35]. References to zombies can
even be found in computing, biotechnology, and artiﬁcial
intelligence [29].
2.3. Composition of the Zombie Poison. As noted throughout
the text, many interesting issues surround zombiﬁcation.
We have highlighted several of these issues in Davis’ report.
Davis’ interdisciplinary approach included documenting the
formulations of the zombie poison and antidote [24]. He
helped to develop the ﬁeld of ethnobiology by answering
questions as an interdisciplinary ethnobiologist that could
not be answered with other modes of inquiry.
DuringhisﬁeldresearchinHaitibetween1982and1984,
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and assisted in their preparation in loco. At the time, he had
two main informants: Marcel Pierre, “an old and faithful
follower of Francois Duvalier”[ 22], and Herard Simon.
From Pierre, Davis learned of a poison preparation that
contained plant and animal material from ﬁve distinct spe-
cies. The preparation related by Simon contained 15 species
encompassed in 13 genera, and his account included the
administrationofapreparationbasedonDaturastramonium
L. (Solanaceae) after zombiﬁcation. Only Pierre revealed the
composition of an antidote, which contained plant material
from ﬁve species, including a plant only identiﬁed by its
genus (see Table 1).
Here, we do not present a complete account of the scien-
tiﬁc research surrounding zombiﬁcation, nor do we address
thecontroversysurrounding the“truth”ofthispractice.This
paper instead aims to recover the composition of the zombie
poison, as reported by Davis, and survey our knowledge of
each of its components (with emphasis on animal-derived
products) and its implications for the development of new
drugs. Davis’ narrative serves as a platform to discuss the
utility of ethnobiological study.
3. Surveyof the CurrentComponents of the
Zombie Poison andAntidote
3.1. Plants. Plant species are the most widely used sources
in folk medicine, with thousands of species used around the
world. (In some cases, the speciﬁc plant parts used in the
poison have not been investigated in chemical and pharma-
cological studies. The speciﬁc plant parts used to prepare the
zombie poison are not known for all species.)
3.1.1. Albizia lebbeck (L.) Benth. Davis’ informants cited A.
lebbeck as a major component of the zombie poison. Pierre’s
preparation employed the fruit, while Simon’s included the
seeds [22]. In various populations in India, the juice of the
rootsofA.lebbeckcombinedwiththoseoftheleavesandbark
ofDiospyrosperegrineisusedtotreatsnakebites[36],asthma
[37], diseases related to vision, night blindness, pyorrhea,
toothache,insectandscorpionbites[38],disordersrelatedto
malefertility [39],wounds, leprosy injuries [40],and various
inﬂammatory conditions [41].
Extracts of A. lebbeck stem bark contain tannins, ﬂa-
vonoids, anthraquinones, saponins, steroids, terpenoids, and
coumarins [41, 42]. Ethanolic extracts and petroleum ether
were tested against four models of inﬂammation in rats (car-
rageenan, dextran, Freund’s adjuvant, and cotton pellet) and
administered at a dose of 400mg/kg. The substances gave
inhibitions ranging from 34.46% to 68.57% [41]. The aque-
ous extract of A. lebbeck showed antimicrobial activity
against nine diﬀerent microorganisms [43]. The methanol
extract of the bark administered to rats aﬀected levels of
testicular androgens by altering spermatogenesis [44], and
the saponins present in the bark interfered with fertility in
rats [45]. Antispermatogenic and antiandrogen activities are
related [44, 46]. A protein called lebbeckalysin, isolated from
the seeds, has antitumor, antibacterial, and antifungal activi-
ties [47]. There are dozens of patents involving this species
and its chemical components (such as a set of herbs with
antiallergenic properties, international publication number
WO 2006067802 A1).
3.1.2.Aloevera(L.)Burm.f. TheantidotedescribedbyPierre
included the leaves of the Aloe vera plant [22]. These leaves
are used to treat leukorrhea [48], hypertension, heartburn,
cancer, dandruﬀ, stomach problems, hair loss, bruises, rheu-
matism, intestinal helminthes, and inﬂammation and are
also used as an emollient [49]. This species is also used to
aid in the healing process [50].
Thisplantcontainsdiversechemicalcompounds,includ-
ing anthraquinones, carbohydrates, enzymes, proteins, vita-
mins, and hormones, of which several exhibit pharmaco-
logical activity [51, 52]. Extracts and chemical components
of A. vera have shown immunostimulant, antimicrobial, an-
tidiabetic, anti-inﬂammatory, wound healing, antioxidant,
anticancer, hepatoprotective, and skin moisturizing eﬀects,
as well as utility in treating skin diseases [51, 52]. This spe-
cies is used in pharmaceutical, hygienic, and cosmetic pro-
ducts [51]. Out of all the species discussed here, A. vera
is represented in most patents. For instance, patent WO
2006055711(A1) describes a preparation containing A. vera
for treatment of neurological syndromes, chronic pain, in-
ﬂammatory bowel disease, and viral infections.
3.1.3. Anacardium occidentale L. Simon cited A. occidentale
as a component of the zombie poison [22]. This species is
widely used in human food and is available commercially
in processed food products. Davis [24] reported that this
species was traditionally used as a purgative, diuretic, febri-
fuge,andcoughtreatment.Theleavesandstembarkareused
to treat diarrhea, kidney infection, heartburn, inﬂammation
of the female organs, tuberculosis, general inﬂammation,
and diabetes and was also used as an antiseptic [49].
A. occidentale’s leaves contain tannins, ﬂavonoids, and
saponins [65]. The hydroalcoholic extract of the leaves did
not produce toxic symptoms in rats at doses up to 2000mg/
kg [65] and showed antiulcer activity [66]. Anacardic acid,
a phenolic compound, has not produced biochemical or
hematological changes in rats at doses below 300mg/kg
[67] and has shown antioxidant activity [68] and cytotoxic
activity against leukemic cells by inducing apoptosis [69].
Anacardic acid derivatives have been patented as antimicro-
bial agents (WO2008062436A2).
3.1.4. Mucuna pruriens (L.) DC. The fruit of M. pruriens
was employed in the poison described by Pierre [22]. In
India,itsseedsaregroundwithalmondsandingestedtotreat
sexual debility and rheumatism and are also used as a tonic
[38]. Haitians use these plants to treat parasitic infections;
a teaspoon of the hair of the M. pruriens fruit (which
contains formic acid and mucunaina) mixed with Psidium
guajava L. is taken before breakfast for three days, causing
severe diarrhea that eliminates worms from the intestine and
stomach [70].
The seeds of M. pruriens contain alkaloids [71], phenolic
compounds, tannins, L-dopa, lectins, protease inhibitors,Evidence-Based Complementary and Alternative Medicine 5
Table 1: Components of the poisons and antidotes used for zombiﬁcation, as related to Davis by informants Marcel Pierre (MP) and Herard
Simon (HS).
Local name Species Family
Poison—MP
Plants
Pois-Gratter/Mucuna Mucuna pruriens (L.) DC. Fabaceae
Tcha-tcha Albizia lebbeck (L.) Benth. Fabaceae
Amphibian
Cane toad Rhinella marina (Linnaeus, 1758) Bufonidae
Fishes
Crapaud de mer Sphoeroides testudineus (Linnaeus, 1758) Tetraodontidae
Fou-fou Diodon hystrix (Linnaeus, 1758) Diodontidae
Antidote—MP
Plants
Aloe Aloe vera (L.) Burm. f. Xanthorrhoeaceae
Bois ca-ca Capparis cynophallophora L. Capparaceae
Bois chandelle Amyris maritima Jacq. Rutaceae
Cadavre gˆ ate Capparis sp. Capparaceae
Cedar Cedrela odorata L. Meliaceae
Roughbark Lignum-vitae Guaiacum oﬃcinale L. Zygophyllaceae
Poison—HS
Plants
Ave Petiveria alliacea L. Phytolaccaceae
Bayahonda Prosopis juliﬂora (Sw.) DC. Fabaceae
Bresillet Comocladia glabra Spreng. Anacardiaceae
Bwa pin´ e Zanthoxylum martinicense (Lam.) DC. Rutaceae
Cana muda Dieﬀenbachia seguine (Jacq.) Schott Araceae
Consigne Trichilia hirta L. Meliaceae
Maman guˆ epes Urera baccifera (L.) Gaudich. ex Wedd. Urticaceae
Mashasha Dalechampia scandens L. Euphorbiaceae
Pomme cajou Anacardium occidentale L. Anacardiaceae
Tcha-tcha Albizia lebbeck (L.) Benth. Fabaceae
Amphibian
Hispaniolan common treefrog Osteopilus dominicensis (Tschudi, 1838) Hylidae
Cane toad Rhinella marina L. Bufonidae
Fishes
Fugu Sphoeroides testudineus (Linnaeus, 1758) Tetraodontidae
Fugu Sphoeroides spengleri (Bloch, 1785) Tetraodontidae
Fugu Diodon hystrix (Linnaeus, 1758) Diodontidae
Fugu Diodon holocanthus (Linnaeus, 1758) Diodontidae
“Postzombiﬁcation paste”—HS
Plants
Zombie cucumber/stramonium Datura stramonium L. Solanaceae
and saponins [72]. This species has shown antioxidant and
chelating activities [73]. The ethanolic extract of these seeds
showed aphrodisiac activity in male rats with no adverse
eﬀects or ulceration at a dose of 200mg/kg [74]. Clinical
studieshaveshownthatM.pruriensregulatessteroidogenesis
and improves semen quality in men with infertility [75].
Studies have shown this species to be an eﬀective treatment
forParkinson’sdiseaseinvivo;thisactivitycouldberelatedto
the presence of L-dopa, an important drug for the treatment
of Parkinson’s disease [76–78]. The aqueous extract of its
seeds has shown hypoglycemic eﬀects [79] .T h es e e d sh a v e
also been shown to be beneﬁcial treatments for venomous
snake bites [80, 81]. M. pruriens extract has been patented
for the treatment of Parkinson’s (WO 2005092359 A1).6 Evidence-Based Complementary and Alternative Medicine
3.1.5. Prosopis juliﬁora (Sw.) DC. P. juliﬁora was a compo-
nentofthepoisondescribedbySimon[21].Braziliansources
record the use of this species’ leaves for the treatment of skin
diseases [49], asthma, bronchitis, conjunctivitis [82]f e v e r ,
warts, gonorrhea, eye problems, parasites, diarrhea, and
ulcers [83–88].
This species contains steroids, alkaloids, coumarins, ﬂa-
vonoids, sesquiterpenes, and stearic acid [89]. The hydroal-
coholic extract of its pollen had antioxidant activity both in
vivo and in vitro [89]. The alkaloid fraction from its leaves
has been observed to have signiﬁcant eﬀects on glial cells,
inducing cytotoxicity, reactivity, and nitric oxide production
[90]. Moreover, it has shown antipyretic, diuretic, antimalar-
ial,antibacterial,hemolytic,andantifungalactivities[85,91–
95]. No drug patents involving this species or its constituents
were found.
3.1.6.CappariscynophallophoraL. Thelea v esofC.cynophal-
lophora were part of Pierre’s antidote preparation [22]. It has
been used to treat cough, pneumonia, ﬂu, digestive prob-
lems, skin diseases, abdominal pain, rheumatism, snakebites,
and digestive problems and has also been used as an emme-
nagogue [49, 96]. Two common ﬂavonoids, kaempferol
and quercetin, have been isolated from this species [97].
Oliveira et al. [9] reported that these ﬂavonoids may exhibit
antinociceptiveactivity[9].Thisspecieswasnotfoundinany
registered patents.
3.1.7. Zanthoxylum martinicense (Lam.) DC. Simon’s poi-
son preparation included Z. martinicense [22]. Davis [24]
reported that, in Cuba, the leaves and bark of this plant were
used as a tonic and to treat syphilis, rheumatism, and alco-
holism. It has also been reported to act as an antispasmodic,
rheumatism treatment, diuretic, and narcotic [98, 99]. A
phytochemical screening revealed the presence of isoquin-
oline alkaloids, triterpenes/steroids, lignans, quinones, lac-
tones/coumarins, tannins/phenols, and saponins [100, 101].
The plant showed antifungal activity against two microor-
ganisms, Microsporum canis and Trichophyton mentagro-
phytes[102].Therewerenoregisteredpatentsforthisspecies.
3.1.8. Guaiacum oﬃcinale L. G. oﬃcinale was used in the an-
tidote described by Pierre [22]. Records of Caribbean natives
using this species as a treatment for reproductive problems
date back to the 16th century [103]. It has also been used to
treat inﬂammation of the stomach, inﬂammatory diseases of
respiratoryorgans,rheumatism,amenorrhea,andgonorrhea
and has been used as a laxative, anticonvulsant, cardiac
depressant, diuretic, diaphoretic, chronic, expectorant, abor-
tifacient, diuretic, purifying treatment, and antidote for acci-
dental poisoning [95, 104–110]. Its chemical composition
includes triterpenes, alkaloids, and various guaianins [111,
112].Itsextractshaveshowninvitroand/orinvivostimulant
activitiesforsmoothmuscle,aswellasabortifacient,diuretic,
antimicrobial, anti-inﬂammatory, and spasmolytic activities
[113–117]. This species is included in several patents; in
one example, its prepared extract was patented to treat skin
inﬂammation and psoriasis (EP1832294A1).
3.1.9. Trichilia hirta L. In Simon’s account, T. hirta was used
to prepare the poison [22]. Davis [24] reported the use of
itsleavestotreatanemia,asthma,bronchitis,andpneumonia
and as a tonic in Cuba. It contains steroids and triterpenes
[118–120]. Its methanolic extract showed no antibacterial
activity against the organisms Escherichia coli and Staphylo-
coccus [121], but antimalarial and larvicidal activities were
reported [122]. This species was not found in any patents.
3.1.10. Petiveria alliacea L. P. alliacea was cited by Simon as
a component of the zombie poison [22]. A substance found
in this species, dibenzyl trisulphide, exhibits antitumor and
immunomodulatory activities [123]. The extract displayed
several mechanisms of action that may explain its antitumor
activity, such as cell cycle arrest in G2 phase, induction of
cytoskeletal reorganization and DNA fragmentation [124].
The benzyl trisulﬁde and benzyldisulﬁde fractions of the
plant’s crude extract showed acaricidal activity in Rhipi-
cephalus (Boophilus) microplus [125]. Several compounds
isolated from this species have antibacterial and antifungal
activities [126, 127]. The extract of P. alliacea showed prom-
i s ea saw o u n dt r e a t m e n t[ 128]. Fractions of the extract of
this species also showed depressant activity in mice [129],
and anti-inﬂammatory and analgesic eﬀects have also been
reported [130]. A product that includes the patented diben-
zyl trisulphide compound was indicated for the treatment of
cancer (20080070839 A1).
3.1.11.Urerabaccifera(L.)Gaudich. U.bacciferawascitedby
Simon as a component of the zombie poison [22]. It is used
as an emmenagogue and to treat persistent fever, skin infec-
tions, snakebites, aches and pains, rheumatism, inﬂamma-
tion, arthritis, gastrointestinal disorders, and gonorrhea [85,
131–135].Ithasanti-inﬂammatoryandanalgesicactivitiesin
vivo [136]. Its extract did not show pronounced leishmani-
cidal activity [135]. No patents relating to this species were
found.
3.1.12. Cedrela odorata L. C. odorata was a component of
the zombie poison antiotde described by Pierre [22]. This
astringent plant is used to treat pain, malaria, fever, aches,
atonic seizures, anemia, gangrene, diarrhea, abdominal pain,
chills, edema, vertigo, coughs, malaise, gastrointestinal pain,
leishmaniasis, stroke, tooth pain, numbness after an insect
bite, and erysipelas and is used as an abortifacient and ver-
mifuge [63, 122, 137–141]. Several compounds have been
isolated from this species, including sesquiterpenes, triter-
penes, ﬂavonoids, steroids, and limonoids [142–145]. No
patents related to this species were found.
3.1.13. Dieﬀenbachia seguine (Jacq.) Schott. D. seguine was
among the components of Simon’s zombie poison prepara-
tion [22]. This plant is considered toxic in many parts of the
world. However, it is used as a choleretic, female aphrodisiac
and contraceptive and to treat dropsy, gout, dysmenorrhea,
sexual impotence, and sterility [98, 146–149].
Tannins, alkaloids, terpenoids, steroids [150], triterpe-
nes, and a great variety of lipid compounds [151]h a v eb e e n
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showed weak antiproliferative activity on a human colon
cancer cell line with IC50 >50µg/mL [150]. The sap of this
species contains toxic metalloproteins that cause necrosis
at the site of contact. A patent describing the use of plant
substances, including a substance from species D. seguine,
as spermicidal and anti-infective agents and as prophylactics
againstsexuallytransmitteddiseasesandthehumanimmun-
odeﬁciency virus has been ﬁled (WO 2007074478 A1). Other
studies have reported vasodilator, hypotensive, antifertility,
contraceptiveand/orinterceptive,andspasmogenicactivities
[152–155].
3.1.14. Datura stramonium L. In Simon’s account, he indi-
cated that D. stramonium, among other ingredients, was
administered after removal of a zombie from the grave [22].
This species is commonly used to treat asthma and as
a hallucinogen. Sixty-seven unique tropane alkaloids have
been detected in its extract. At certain concentrations, this
plant is known to induce delusions and altered mental states
[156]. Agglutinin, a lectin isolated from D. stramonium, in-
hibited proliferation and induced diﬀerentiation in glioma
cells [157]. There are thousands of patents related to scopo-
lamine (a commercialized pharmaceutical product) directly
or indirectly. One example of these is a European patent
application for the treatment of depression and anxiety (WO
2006127418 A1).
3.1.15. Dalechampia scandens L. D. scandens was a compo-
nent of Simon’s zombie poison preparation [22]. It is used
to treat cough and ﬂu [122], and cytotoxic activity has been
reported [158]. No patents related to this species were found.
Comments. Plants have been the main source of molecules
forthedevelopmentofnewdrugs.Craggetal.[159]reported
that “more than 60% of anticancer agents used are derived
from natural products.” Signiﬁcant plant-derived medicinal
substances include elliptinium, etoposide, irinotecan, taxol,
vincristine, and teniposide, among others [159].
Generally, the components of the poison by Pierre and
Simon [22] would be expected to have toxic eﬀects, while
those of the antidote might have beneﬁcial eﬀects (detox-
ifying, hepatoprotective, or immunomodulatory activities,
e.g.).
M. pruriens, P. alliacea, U. baccifera, D. seguine, and D.
stramonium were all cited as poison components. The seeds
of M. pruriens have been shown to be eﬀective in in vivo
studies and clinical trials for the treatment of Parkinson’s
disease and contain a compound that is commercially ex-
ploited for this purpose [160]. The extract of M. pruriens
and speciﬁcally L-dopa has proven eﬀective in the treatment
of many symptoms, such as tremor, diﬃculty in movement,
diﬃculty walking, and depression, in the pathology of
Parkinsons. P. alliacea and U. baccifera show analgesic ac-
tivity [22]. D. seguine may facilitate the absorption of the
bioactive substances of the poison, because this species
causes irritation in the epidermis. The studies also indicate
that D. stramonium is a potent hallucinogen; this activity
maybeduetoanticholinergicactivitytriggeredbyitstropane
alkaloids, such as hyoscyamine and scopolamine, which may
be metabolized into atropine.
A. vera used as an antidote may be due to any number of
its observed beneﬁcial properties, including immunostimu-
lant, antioxidant, and hepatoprotective activities.
A sizeable obstacle in understanding the pharmacolog-
ical mechanisms and eﬀects of the zombie poison is the
disparate chemical and pharmacological components in its
preparation. This diversity makes it diﬃcult to disentangle
each species’ speciﬁc role. Such preparations combining tra-
ditional components often act on not only physiological
but psychological and spiritual levels. Study of the role of
each compound could provide clues about their roles in the
poison.
Although the majority of plant species considered here
have been the subject of at least one in vitro or in vivo phar-
macological study, and they contain dozens of known bioac-
tive molecules, research on the pharmacological basis of the
process of zombiﬁcation is not conclusive; the role of each
of the molecules involved in this process is not yet known.
Almost 30 years after Davis’ research, there are still many
unanswered questions.
3.2.Amphibians. Vertebratespeciesareamongtheleast-used
in folk medicine; approximately 29 species are known to be
employed [161, 162].
3.2.1.Rhinellamarina(Linnaeus,1758)(BugaToad). Rhinel-
lamarina(Linnaeus,1758),alsoknownasthecommontoad,
large buga toad, or cane toad, has undergone several modi-
ﬁcations in the genus and epithet (Bufo marinus Schneider,
1799; Bufo marinus Gravenhorst, 1829; Bufo angustipes
Taylor & Smith, 1945; Bufo pythecodactylus Rivero, 1961;
Bufo marinus Cei, Erspamer & Roseghini, 1968) but has
always been classiﬁed within the family Bufonidae [163–
166]. This species is native to Central America (Belize, Costa
Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua,
Panama, and Trinidad and Tobago) and South America (Bo-
livia, Colombia, Ecuador, Guyana, French Guiana, Peru, Su-
riname,Venezuela,andthesouthernportionofBrazil)[166–
170].
The buga toad was likely introduced into Haiti from
explorers’ ships or as a biological form of pest control [171,
172]. Because it is aggressive and highly dispersive, this toad
is found in both natural and urban environments and is
abundant everywhere it is found [173]. It is nocturnal in sev-
eral ecosystems, including the Amazon rainforest, savanna,
humid woodlands, equatorial dry forests, agroecosystems,
and urban areas, with population peaks in open and altered
areas [173]. It can be found in many microhabitats, such
as leaf litter, holes in buildings, falling trees, branches, and
leaves [174]. R. marina’s rising population requires urgent
conservation measures to prevent local extinction of native
species, and it represents a major threat to frog fauna [164,
175, 176].
Species in the family Bufonidae derive toxic and phar-
macological properties from granular glands in their backs
[177], which biosynthesize several chemical compounds
for protection from predators and microorganisms [178].8 Evidence-Based Complementary and Alternative Medicine
These properties make this family valuable as a source of
bufotoxins, a class of bioactive molecules [179]. It is also
a signiﬁcant cause of injury for domestic and wild animals,
mainly resulting from predation attacks [180]. Substances
isolated from the skin of these toads, referred to as “dendro-
batid alkaloids,” are used as antimicrobial agents, a chemical
defense against predators, irritants, hallucinogens, convul-
sants, nerve poisons, and vasoconstrictors. The alkaloid epi-
batidine, a painkiller 200 times more potent than morphine,
was also derived from this family, being found in some
species of poison dart frogs. Other such alkaloids include
batrachotoxins (sodium channel activators), histrionicotox-
ins (noncompetitive blockers of nicotinic channels), decahy-
droquinolines, various izidines, epibatidine (a potent nico-
tinic agonist), tricyclic coccinellines, pseudophrynamines,
and spiropyrrolizidines (potent noncompetitive blockers of
nicotinic channels) [181] and the pumiliotoxin, allopumil-
iotoxin, and homopumiliotoxin group.
3.2.2. Bufo bufo (Linnaeus, 1758). Bufo bufo (Linnaeus,
1758),popularlyknownasthecommontoad,isacomplexof
Bufonidaespecies.Areviewoftheliteratureconcerningthese
species is urgently needed, as Bufo bufo was synonymized
with Bufo vulgaris (Laurenti, 1768), which became a null
clade in conventional taxonomy [164, 166, 182, 183]. This
species was observed ﬁrst across almost all of Europe (except
Ireland), most islands in the Mediterranean, the Middle East
(Lebanon, Syria and Turkey), and North Africa (northern
coast of Morocco, Algeria, and Tunisia) [182]. Although
reported by Davis [22], it is not a native species of Haiti and
was likely introduced during the colonization of the Hispan-
ioladuringthefrequentcontactwithlargevesselsoriginating
from the Iberian Peninsula, especially Spain. However, to the
best of our knowledge, there are no taxonomic occurrences
of this species in Haiti. Bufo bufo is a habitat generalist
and is found in urban areas, coniferous forests, seasonal
forests, woodlands, meadows, and arid environments [184].
It is remarkable for its stable populations in areas where
it is endemic. It has therefore attracted little concern from
theInternationalUnionforConservationofNature—IUCN,
although it is classiﬁed as near-threatened in Spain due to a
sharpdecreaseinitspopulationfromconstanttramplingand
climate change [185–187].
3.2.3. Osteopilus dominicensis (Tschudi, 1838). Osteopilus do-
minicensis Tschudi, 1838, a member of the family Hylidae
[164, 166, 188, 189], is endemic to Haiti and the Dominican
Republic [188, 190, 191] and is found at altitudes from sea
levelto2000m[171,172,188,192].Itisfoundinlenticwater
bodies in open environments, forests, and agroecosystems,
especially on the edges of permanent or temporary ponds
[189, 190]. Like all hylids, its arboreal habits are facilitated
by its adhesive discs [177], and it commonly uses bushes as
vocalization sites [189, 190]. It is remarkable for its stable
populations in areas where it is endemic. It has therefore
attracted little concern from the International Union for
ConservationofNature—IUCN,althoughsomestudieshave
detected reductions in some isolated populations [188, 189,
193]andhaverecommendedprotectionoftheirreproductive
sites as a primary conservation measure [189, 193, 194]. We
found no reports of the chemical composition of its skin
or pharmacological activity related to this species or species
of phylogenetically related genera such as Osteocephalus and
Phyllodytes [164].
Comments. For centuries, the skin of amphibians, especially
those of the genus Bufo, has been used in traditional Chinese
and Japanese medicine [129]. Gomes and Colleagues [129]
reported that these skins provide a wide range of bioactive
compounds with diﬀerent therapeutic potentials, including
antiprotozoal, antiviral, antineoplasic, cardiotonic, antiar-
rhythmic, antidiabetic, immunomodulatory, antibacterial,
antifungal, sleep-inducing, analgesic, contraceptive, behav-
ior-changing,woundhealing,andendocrineactivities(other
than insulinotropic). The molecules identiﬁed include bufo-
genins, bufadienolides, or bufotoxins, which, interestingly,
have chemical structures that interact with the cyanogenic
glycosides present, for example, in the plant Digitalis pur-
purea [195]. These authors reported vasoconstrictor activity
from the skin secretions of Rhinella marina in an experimen-
tal model of umbilical artery rings and placental vessels.
Thequalityandquantityofbufadienolidesfromthisspe-
cies, for example, vary signiﬁcantly during ontogenetic de-
velopment, especially in eggs [196]. Gao et al. [197]f o u n d
at least 43 compounds in methanol extracts from the
genus Bufo, including commercial samples. These authors
reported, from various sources, that at least 100 compounds
have been identiﬁed, including bufadienolides and indole
alkaloids. Despite reports of potential oncological appli-
cations of these substances, their adverse eﬀects, such as
cardiotonic action [129], are a source of concern. This car-
diotoxicity is widely known, having been recorded for many
species, including Bufo viridis [198]. Although we have res-
ervations about the records of Bufo bufo in Haiti, this
species is widely used in traditional oriental medicine. Gao
et al. [197] observed, through an analysis of geographical
variations, that in many cases the chemical composition
of Bufo venom did not meet the requirements of Chinese
pharmacopoeia.
Davis’ informants provided information about the am-
phibians used to prepare the zombie poison [22]. The two
formulations are quite diﬀerent, both in their components
(Table 1)andmodesofpreparation.Davisreportedthatboth
poisons employed both the common toad and the marine
toad. He was likely referring to Bufo bufo (because in his
work, he refers to this species similarly in other contexts)
and Rhinella marina. One of the poisons also included the
skin of the frog Osteopilus dominicensis. The ingredients of
this poison were highly diverse and caught Davis’ attention
[22]. From an ethnopharmacologic perspective, the desired
activitymaybeobtainedthroughsuchadditionsduetointer-
actions among the drugs present. However, it is also possible
that such additions were used only to give importance and
status to the manufacturer of the poison, and do not impact
its pharmacologic activity.
3.3. Fish. Fish are among the animals most frequently used
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in Latin America are used in traditional medical systems
[161].
3.3.1. Sphoeroides testudineus (Linnaeus, 1758). Known as
the puﬀer ﬁsh, painted puﬀer ﬁsh, or pining puﬀer ﬁsh,
S. testudineus is found in the western Atlantic from New
Jersey to Santa Catarina and is the most abundant species on
the Brazilian coast [199–201]. It lives in bays and estuaries,
reaching and entering freshwater, and reaches 25cm in total
length [199]. It is reef-associated and may spend its entire
life cycle in estuarine waters. It is very abundant in ﬁsh
assemblages in estuaries and bays [202–204]. This species,
like others from the family Tetraodontidae, can as, a defense
mechanism, inﬂate its body through ingestion of water or
air. It feeds mainly on crustaceans, mollusks, plants, and
invertebrates [205]. It reproduces by external fertilization in
open waters by placing eggs on substrates and has a mean
total length of 13cm at sexual maturity [206]. It contains
tetrodotoxin, a potent ichthyotoxin found in its skin, liver,
and gonads, where it acts as pheromone [207]. This potent
neurotoxin, also known as “tetrodox,” blocks potential
actions in nerves by blocking voltage-gated, fast sodium
channels in nerve cell membranes, preventing aﬀected nerve
cells from ﬁring. The biological actions of the tetrodox
include paresthesias [208] of the lips and tongue, followed
by sialorrhea, sweating, headache, weakness, lethargy, ataxia,
tremors, paralysis, cyanosis, aphonia, dysphagia, seizures,
dyspnea, bronchorrhea, bronchospasm, respiratory failure,
coma, and hypotension. In aﬀected organisms, cardiac
arrhythmias may precede a complete respiratory failure and
cardiovascular collapse [209].
3.3.2. Sphoeroides spengleri (Bloch, 1785). Like S. testudineus,
Sphoeroides spengleri is also commonly known as the puﬀer
ﬁsh or pining puﬀer ﬁsh. S. spengleri is distributed in the
western Atlantic from Mass, USA to Sao Paulo, Brazil [199,
200]. It is found in shallow waters near the coast that are
not exposed to freshwater and is common on reefs. This
species has high levels of tetrodotoxin in its muscles, skin,
and viscera that constitute a risk to its predators, while the
levels in puﬀer ﬁshes of the genus Lagocephalus are smaller,
suggesting a lower risk. However, there are no concrete data
on this type of poisoning [210, 211]. S. spengleri feeds on
mollusks, crustaceans, and echinoderms and reaches 15cm
[199]. It is often consumed by ﬁshermen along with species
of Lagocephalus laevigatus [210, 212], although most are
captured for ﬁshkeeping.
3.3.3. Diodon holocanthus (Linnaeus, 1758). Known as spiny
puﬀer ﬁsh, D. holocanthus is a widely distributed species
found in almost all tropical areas of the western Atlantic,
from Florida to southern Brazil. This marine species is
associated with living reefs and reaches 30cm [199]. In
Brazil, it has been recorded in both shallow and deep coral
reefs and always within the substrate, although not in abun-
dance [213]. Spiny puﬀer ﬁshes are nocturnal and are ben-
thopelagic adults and pelagic juveniles. This species lives
alone and feeds on mollusks, sea urchins, and crabs [214].
Members of the family Diodontidae can inﬂate their bodies
by ingesting water or air as a complementary defense mech-
anism to their spikes. D. holocanthus is used in ﬁsheries and
is of great importance in ﬁshkeeping [215].
3.3.4. Diodon hystrix (Linnaeus, 1758). D. hystrix, like the
species above, is also known as spiny puﬀer ﬁsh. It is found
in tropical and temperate regions worldwide. In the western
Atlantic, it can be found from Massachusetts to southern
Brazil [199]. This ﬁsh reaches 60cm, has a relatively long
pelagicstage,andfeedsatnight,withadietmainlyconsisting
of clams, crabs, and sea urchins [199]. It inhabits marine
environments and lives in coral reefs up to 50m deep. It lives
alone and has nocturnal habits. They feed on invertebrates
like sea urchins, gastropods, and hermit crabs [214]. It is not
normally used as food, is rarely ﬁshed, and is instead used
mostly as a commercial ﬁshkeeping species [215].
Comments. Saxitoxin (STX) and tetrodotoxin (TTX), ob-
tained from the above species [216], are considered key
components in inducing catalepsy or motor paralysis, fun-
damental actions of the zombie poison [28].
However, there is evidence that other neurotoxic and cy-
totoxic substances are involved in zombie poison [216].
Landsberg et al. [217], compiling information from prior
reports, reported that while TTXs and STXs are chemically
diﬀerent, they produce similar biological responses in mam-
mals, including tingling and numbness of the mouth, lips,
tongue, face, and ﬁngers, paralysis of the extremities, nausea,
vomiting, ataxia, drowsiness, diﬃculty in speaking, and pro-
gressively decreasing ventilation eﬃciency. A comparison of
these symptoms with the descriptions of zombiﬁcation rein-
forces the hypothesis that these neurotoxins are responsible
for the phenomenon.
In a recent review, Zimmer [31] described the mecha-
nisms and actions of TTX on the cardiovascular system of
mammals. These actions include, depending on the dose,
bradycardia, hypotension, a rapid drop in blood pressure,
cessation of breathing, and dissociation/cessation of ven-
tricular contractions. There is a set of clinical criteria for
diagnosingTTXexposure;Table 2 comparesthesesymptoms
tothosesymptomsreportedbyDavis[22]forcasesofzombie
poisoning. This comparison also reinforces the hypothesis
thatTTXpoisoningplaysanimportantroleinzombiﬁcation.
Wedonotintendtoevaluatetheclaimsonthezombiﬁca-
tion here, given the complexity and controversy surrounding
the issue. As Littlewood and Douyon [28] suggested, there
is no single explanation for zombies, but mental disorders
and equivocal identiﬁcation may be plausible explanations.
These authors studied three cases of possible zombiﬁcation
occurring between 1996 and 1997 in Haiti. At least two of
those cases were equivocal identiﬁcations in which families
claimed to recognize a deceased relation. Genetic analysis
in these two cases showed that the zombies had no kin-
ship with the people who recognized them. On this topic,
Littlewood and Douyon [28] wrote, “What is more diﬃcult
to understand is the apparent acquiescence of the “returned
relative” not only to being a zombie but to being a
“relative.”” Zombiﬁcation is therefore a phenomenon that10 Evidence-Based Complementary and Alternative Medicine
Table 2: Clinical grading system for TTX poisoning as described by Fukuda and Tani [30] and modiﬁed by Zimmer [31].
Clinical grading system Description of zombiﬁcation [22]
First, “oral numbness and paraesthesia, sometimes
accompanied by gastrointestinal symptoms (nausea)” Digestive disorders with vomiting.
Second, “numbness of face and other areas, advanced
paraesthesia, motor paralysis of extremities, incoordination,
slurred speech, but still normal reﬂexes.”
—
Third, “gross muscular incoordination, aphonia, dysphagia,
dyspnoea, cyanosis, drop in blood pressure, ﬁxed/dilated pupils,
precordial pain, but victims are still conscious.”
—
Fourth, “severe respiratory failure and hypoxia, severe
hypotension, bradycardia, cardiac arrhythmia, heart continuing
to pulsate for a short period.”
Pronounced breathing diﬃculties, pulmonary edema, hyperten-
sion, hypothermia, renal failure, and rapid weight loss.
transcends psychopharmacologically and reminds us of the
need for understanding social and cultural context. To var-
ying degrees, traditional medicines worldwide interact with
a web of relationships beyond medicine and physiology.
4. Medicaland PharmaceuticalImplications
TTX has received more attention than other natural marine
products due to its potent inhibition of sodium channels.
Although biotoxins have been the subject of research for
about 70 years, only in the past 10 has signiﬁcant progress
been made [218], as illustrated by the growing number of
publications. Until 2007, formulations containing TTX had
not been approved for use in the United States [218]. Several
patents have been deposited, such as one owned by Wex
Pharmaceutical Inc. for the use of TTX and STX in pain
management.
Among amphibians, the most studied species is most
likely Rhinella marina (Linnaeus, 1758), presumably due to
its wide distribution and abundance. Until 2000, despite its
continued use in traditional Chinese medicine, few studies
had been conducted on its pharmacological properties,
therapeutic potential, or toxicity [219]. However, interest in
TTX and STX has considerably raised this species’ proﬁle.
Bufadienolides have been reported as excellent cardiotonics
and as a possible alternative to drugs available on the market
[220]. Nevertheless, to the best of our knowledge, there is
only one registered patent in the United States (936 063) for
an antifungal and antimicrobial peptide derived from Bufo
bufo gargarizans (now known as Bufo gargarizans)( C a n t o r ,
1842).
The scenario sketched here shows the pharmacological
potential of animal toxins. This potential invites scientiﬁc
investment, especially in the cases above, which are widely
distributed and abundant and also display promising and
relevant pharmacological activities. Even considering the
status that these animals gained from Davis’ ethnobiological
reports [22] and all the following controversy, progress is
slow, despite the obvious potential for the development of
new drugs. One issue is that many organisms are studied for
theirchemistryandbiologicalactivityfromanecologicaland
evolutionary perspective. In the next section, we discuss how
ethnographicalknowledgeoffolkmedicinecanbeemployed,
with speciﬁc reference to zombie poison.
5. Pharmacological Studies of Animals Used in
Folk Medicine
Although research on animal use in folk medicine is still in
its initial stages, it has intensiﬁed in recent years, especially in
Latin America (mainly Brazil and Mexico), Africa, and Asia.
These surveys have found an impressive number of animals
used in folk medicine. At least 1,500 animal species are
known to be used in traditional Chinese medicine [221], and
at least 587 are used in Latin America [161]; these numbers
are likely to increase dramatically with additional research.
Mostmedicinalanimalsusedintraditionalfolkmedicine
are vertebrates, although signiﬁcant quantities of inverte-
brates (mainly insects) are also used. In general, the groups
with the largest numbers of medicinal species were mam-
mals, birds, ﬁshes, and reptiles. Amphibians comprise the
least common group among medicinal vertebrates. World-
w i d er e v i e w sr e p o r ta tl e a s t1 6 5s p e c i e so fr e p t i l e s[ 222], 101
species of primates [223], 55 species of bovidae [224], and
46 carnivorous mammals [14, 223] used in traditional folk
medicine.
Pharmacological approaches that test the activity of ani-
mal products based on traditional knowledge are relatively
rare(Table 3). Few studies in the literature use this approach;
most ethnopharmacological research is instead focused on
plants [19]. However, it is possible that some studies have
made use of ethnographic information but did not explicitly
state this.
These studies are largely related to animals used in devel-
oping countries, with Brazil and China being the targets of
four investigations and the medicinal animals of India and
Saudi Arabia the focuses of three and one study, respectively.
Studies with this approach are more common in developing
countries because such countries depend on natural prod-
ucts to satisfy their medical needs [225]. China and Brazil
havebeenreportedtohavehighratesofplantandanimaluse
for medicinal purposes [225], as can be seen in our survey of
natural products.
Interestingly, nine of the studies tested the therapeutic
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Table 3:Survey ofninepharmacological studiesbased onfolkknowledge ofmedicinal animals. ∗Whilethelistedactivitywasdetected,there
is no indication that the compound is popularly used for this purpose.
Order Family Species Popular
name Detected activities Reference
Artiodactyla Camelidae Camelus dromedarius Dromedary Cytotoxicity [53]
Carnivora Ursidae Ursus thibetanus Bear Anti-inﬂammatory,
anticonvulsant, analgesic [54]
Carnivora Ursidae Ursus arctos Bear Anti-hepatitis C [55]
Galliformes Phasianidae Pavo cristatus Peacock Anti-snake venom [56]
Haplotaxida Megascolecidae
and Lampito mauritii Earthworm Anti-inﬂammatory,
antipyretic [57]
Isoptera Termitidae Odontotermes
formosanus Termite Antimicrobial [58]
Isoptera Termitidae Nasutitermes corniger Termite Antimicrobial [59, 60]
Perissodactyla Rhinocerotidae Diceros bicornis Rhino Antipyretic [61, 62]
Squamata Teiidae Tupinambis merianae Tegu Anti-inﬂammatory,
antimicrobial [63, 64]
while only three works employed invertebrates. This discrep-
ancy is surprising because the regulations regarding verte-
brates, even for research purposes, are generally much more
restrictive than those for invertebrates. Moreover, vertebrate
conservation is a more pressing issue than that for inverte-
brates [226].
Animal-derived products were assayed most often for
antimicrobial activity (4 studies) and inﬂammatory and an-
tipyretic activities (3 studies each). These three indications
are also among the most common tests of eﬃciency for
plant-based therapeutic natural products [227–230]. These
tests are common because they are relatively simple, easy to
conduct, and inexpensive and because of the high frequency
of natural products indicated to treat them; they are well-
studied and, therefore, have led to a vast number of natural
product treatments.
Despite the prevalence of antimicrobial activity in phar-
macological studies, such activity was found only once in
vertebrate studies; it was found commonly, however, in stud-
ies of invertebrates. The prevalence of antimicrobial activity
in invertebrates may be due to syntheses of toxins and other
substances that can damage bacterial membranes or decrease
their ability to multiply [19]. Some herbivorous inverte-
brates (such as insects) can concentrate secondary plant
compounds, which may contribute to their anti-microbial
activity [19].
Moreover, plant substances with antipyretic and anti-
inﬂammatory activities are used more commonly than those
of vertebrate origin. In fact, studies have found compounds
fromplants,suchassaponinsandterpenoids,inthechemical
composition of various animal venoms [231]. However, ver-
tebrates can also concentrate those substances, although in
many cases they are derived from insects or are present in
their biological composition [15]. For example, tribes in
South America apply poison from the skin of poison dart
frogs (of the family Dendrobatidae) to arrow tips used for
hunting. However, most of the alkaloids that are known to
give these frogs their toxic properties are derived directly
from arthropods in their diets, which are mostly made up
of insects [232, 233].
It is noteworthy that, in studies of the venom of Anura,
there has been little investigation of the correlation between
diet and bioactive biosynthesis because most research related
to frog diets is limited to identiﬁcation of their prey [234–
236]. Frog diets generally exceed their energy requirements,
as they are also used to produce toxins. This behavior is evi-
dencedbyresearchconductedwiththefamilyDendrobatidae
clade, which is found predominantly in tropical region, that
found signiﬁcant production of toxins among anurofauna
[177, 237].
Some of the most commonly used pharmacological
assays include measurement of the rectal temperatures of
mice (three studies), analysis of minimum inhibitory con-
centrations (MICs) (three studies), and tests of mouse paw
and ear edemas (two studies each). These tests reﬂect the
most studied therapeutic indications.
This survey emphasizes the great potential of medicinal
products obtained from zootherapy. In a more critical anal-
ysis, although interesting biological activities have been
found, in our view, none was suﬃciently potent to suggest
potential for drug development. Additionally, such research
carries implications for conservation because the amount of
biomass required for such studies is substantial, and some
speciesareendangeredorvulnerable.Alltheseaspectsshould
be taken into consideration when designing studies, ethno-
graphically inspired or otherwise, of medicinal animals.
6. Final Considerations
In this paper, we emphasize the great potential for study
of medicinal animals from traditional knowledge, given the
large number of species used worldwide. There is strong
evidence of signiﬁcant and relevant biological activities in
vertebrate and invertebrate animals. The ethnobiology of the
zombie poison, which contains ingredients used in many
folk medical traditions that have led to the development12 Evidence-Based Complementary and Alternative Medicine
of medically and pharmacologically important drugs, is an
objective illustration of the role of traditional knowledge in
modern drug discovery.
Although we found few pharmacological studies directly
derived from zootherapy or ethnozoological studies, such
studies are promising sources of potential new drugs. Thus,
we recommend additional eﬀort to develop pharmacolog-
ical discovery studies using traditional medicinal animals.
However, to balance the scientiﬁc and social impacts of
this research, knowledge of each species natural history is
required. This information will allow sustainable use of each
species, allowing natural recovery and recruitment. Species
of the family Bufonidae, especially the genera Bufo and
Rhinella (Amphibia), and ﬁsh of the families Tetraodontidae
and Diodontidae are promising candidates for investigation,
both for their toxicological potential and as models of
biosynthesis. Their favorable properties include signiﬁcant
toxin production, eﬃcient metabolic pathways, potent bio-
logical activity, and their relative abundance. Surprisingly,
there are still few studies on these species, despite the two
extensively studied toxins, TTX and STX. Dozens of sub-
stances, some with neurotoxic and cytotoxic activity, can be
recovered from these species. The few patent applications
found underline the need for change in research method-
ologies and the wealth of biochemistry that has yet to be
discovered.
These natural products are used in traditional medical
systems by peoples around the world. They are present in
their practices and strongly embedded in their culture. Un-
derstanding these phenomena may also prove useful for un-
derstanding how these medical systems have developed,
especially in situations with limited access to the resources
of modern medicine.
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